本发明涉及生物医药领域，具体涉及一种基于岩藻糖基化细胞外囊泡中差异化表达miRNA的肝癌预测模型建立及应用，通过GlyExo糖捕获技术快速有效的捕获样本中岩藻糖基化细胞外囊泡，通过NGS测序技术、生信分析技术可有效获得肝癌患者样本的差异化表达miRNA的组合，共涉及75个差异化表达miRNA，通过对差异化表达miRNA单变量分析、或模型组合分析，可有效区分肝癌样本和非肝癌样本，充分体现了基于糖基化细胞外囊泡miRNA在肝癌诊断领域具有重大的临床应用前景。本发明为肝癌早期诊断提供了一种与现有检测方法完全不同的全新检测策略，可有效避免现有检测方法的缺陷，其综合应用的临床(56)对比文件Jian Pu等.Long noncoding RNA SNHG14facilitates hepatocellular carcinomaprogression through regulating miR-4673/SOCS1.American journal of translationalresearch .2021,第11卷(第9期),5903页左栏第2段.Wang B,等.miR-145-5p Acts as a NovelTumor Suppressor in HepatocellularCarcinoma Through TargetingRAB18.Technology in Cancer Research &Treatment.2019,第18卷(第1期),摘要和第5页右栏最后一段.Sara M Atwa,等.Pivotal role of longnon-coding ribonucleic acid-X-inactivespecifictranscript in regulating immunecheckpoint programmed deathligand 1through a shared pathway between miR-194-5p and miR-155-5p in hepatocellularcarcinoma.World Journal ofHepatology.2020,第12卷(第12期),第1222页最后一段和图9.Zhoujing Zhang等.Serum miR-483-5p asa potential biomarker to detecthepatocellular carcinoma.Hepatologyinternational.2012,第7卷(第1期),第199页左栏摘要.Ya Wen等.Serum levels of miRNA inpatients with hepatitis B virus-associated acute-on-chronic liverfailure.Hepatobiliary & PancreaticDiseases International.2018,第2018卷(第17期),第126页摘要.Mingzhe Zhu等.Integrated analysis ofhepatic mRNA and miRNA profilesidentified molecular networks andpotential biomarkers of NAFLD.ScientificReports.2018,第2018卷(第8期),第1页摘要.Liang Li等.erum miRNAs as predictiveand preventive biomarker for pre-clinicalhepatocellular carcinoma.CancerLetters.2016,第273卷(第2期),第1页摘要.徐学文.糖基化标志物在肝胆肿瘤临床诊断中的应用研究.硕士学位论文电子期刊.2021,第2021卷(第9期),1-72.田银平等.哺乳动物核心岩藻糖基化研究进展.浙江大学学报(农业与生命科学版).2021,第,47卷(第1期),1-10.Jian Pu等.Long noncoding RNA SNHG14facilitates hepatocellular carcinomaprogression through regulating miR-4673/SOCS1.American journal of translationalresearch .2021,第11卷(第9期),5903页左栏第2段.Wang B,等.miR-145-5p Acts as a NovelTumor Suppressor in HepatocellularCarcinoma Through TargetingRAB18.Technology in Cancer Research &Treatment.2019,第18卷(第1期),摘要和第5页右栏最后一段.Sara M Atwa,等.Pivotal role of longnon-coding ribonucleic acid-X-inactivespecifictranscript in regulating immunecheckpoint programmed deathligand 1through a shared pathway between miR-194-5p and miR-155-5p in hepatocellularcarcinoma.World Journal ofHepatology.2020,第12卷(第12期),第1222页最后一段和图9.Zhoujing Zhang等.Serum miR-483-5p asa potential biomarker to detecthepatocellular carcinoma.Hepatologyinternational.2012,第7卷(第1期),第199页左栏摘要.Ya Wen等.Serum levels of miRNA inpatients with hepatitis B virus-associated acute-on-chronic liverfailure.Hepatobiliary & PancreaticDiseases International.2018,第2018卷(第17期),第126页摘要.Mingzhe Zhu等.Integrated analysis ofhepatic mRNA and miRNA profilesidentified molecular networks andpotential biomarkers of NAFLD.ScientificReports.2018,第2018卷(第8期),第1页摘要.(续)